北京中医药大学学报(中医临床版)
北京中醫藥大學學報(中醫臨床版)
북경중의약대학학보(중의림상판)
JOURNAL OF BEIJING UNIVERSITY OF TRADITIONAL CHINESE MEDICINE(CLINICAL MEDICINE)
2013年
4期
11-13,14
,共4页
周琴%左明焕%李泉旺%姜敏%孙韬%肖俐%乔占兵%胡凯文
週琴%左明煥%李泉旺%薑敏%孫韜%肖俐%喬佔兵%鬍凱文
주금%좌명환%리천왕%강민%손도%초리%교점병%호개문
恶性胸腹水%华蟾素注射液%胸腹腔药物灌注治疗%血性胸腹水%中医局部辨证
噁性胸腹水%華蟾素註射液%胸腹腔藥物灌註治療%血性胸腹水%中醫跼部辨證
악성흉복수%화섬소주사액%흉복강약물관주치료%혈성흉복수%중의국부변증
malignant hydrothorax and ascite%Huachansu Injection%perfusion treatment in thorax and abdomen%bloody hydrothorax and ascite%local syndrome differentiation of TCM
目的观察华蟾素胸腹腔灌注治疗恶性胸腹水的临床疗效与安全性,初步探讨其机制。方法共纳入符合标准的恶性胸腹水患者30例,留置胸腹腔引流管,尽量排尽胸腹水后给予生理盐水250 mL+华蟾素注射液40 mL胸腹腔灌注。每周3次,2周为1个疗程。1个疗程后根据胸腹水量、肿瘤标记物(TM)、红细胞(RBC)及患者症状进行疗效评价。结果总有效率46.67%;75.00%(12/16)肉眼血性胸腹水患者治疗后红色明显变浅;大部分患者胸腹水中TM、RBC水平明显下降。结论华蟾素胸腹腔灌注治疗局部辨证为湿热毒证的恶性胸腹水具有一定疗效。
目的觀察華蟾素胸腹腔灌註治療噁性胸腹水的臨床療效與安全性,初步探討其機製。方法共納入符閤標準的噁性胸腹水患者30例,留置胸腹腔引流管,儘量排儘胸腹水後給予生理鹽水250 mL+華蟾素註射液40 mL胸腹腔灌註。每週3次,2週為1箇療程。1箇療程後根據胸腹水量、腫瘤標記物(TM)、紅細胞(RBC)及患者癥狀進行療效評價。結果總有效率46.67%;75.00%(12/16)肉眼血性胸腹水患者治療後紅色明顯變淺;大部分患者胸腹水中TM、RBC水平明顯下降。結論華蟾素胸腹腔灌註治療跼部辨證為濕熱毒證的噁性胸腹水具有一定療效。
목적관찰화섬소흉복강관주치료악성흉복수적림상료효여안전성,초보탐토기궤제。방법공납입부합표준적악성흉복수환자30례,류치흉복강인류관,진량배진흉복수후급여생리염수250 mL+화섬소주사액40 mL흉복강관주。매주3차,2주위1개료정。1개료정후근거흉복수량、종류표기물(TM)、홍세포(RBC)급환자증상진행료효평개。결과총유효솔46.67%;75.00%(12/16)육안혈성흉복수환자치료후홍색명현변천;대부분환자흉복수중TM、RBC수평명현하강。결론화섬소흉복강관주치료국부변증위습열독증적악성흉복수구유일정료효。
Objective To observe the curative effect and safety of Huachansu Injection poured into thorax and abdomen in the treatment of malignant hydrothorax and ascite, and discuss the mechanism initially. Methods The patients with malignant hydrothorax and ascite (n=30) were chosen and given the perfusion treatment in thorax and abdomen three times a week (250 mL normal saline and 40 mL Huachansu Injection) after draining pleuroperitoneal fluid. One therapeutic course was two weeks. After one therapeutic course, the review on curative effect was conducted according to quantity of pleuroperitoneal fluid, tumor marker (TM), RBC count and symptoms. Results The total effective rate was 46.67%. The red color became lighter in 75.00% (12/16) patients with bloody hydrothorax and ascite by naked eye. The levels of TM and RBC count decreased significantly in the most of patients. Conclusion The perfusion treatment of Huachansu Injection has certain curative effect on malignant hydrothorax and ascite diagnosed as syndrome of dampness heat toxin.